BACKGROUND:We examined the relationship between weight change in the year before radical prostatectomy (RP) and biochemical recurrence (BCR) and adverse pathology.
METHODS:We abstracted data from 359 men undergoing RP in the SEARCH (Shared Equal Access Regional Cancer Hospital) database between [2001][2002][2003][2004][2005][2006][2007]. Logistic regression and Cox proportional hazards models were used to test the association between weight change in the year before surgery and adverse pathology and BCR, respectively.
RESULTS:In all, 152 (42%) men gained weight, 193 (54%) lost weight and 14 (4%) had the same weight. Among weight gainers, median gain was 2.4 kg and among weight losers, median loss was 2.7 kg. As a continuous variable, weight change was not associated with adverse pathology or BCR (all P40.05). In secondary analysis, on multivariate analysis, men gaining X2.5 kg were at higher BCR risk (hazards ratio ¼ 1.65, 95% confidence interval (CI): 1.03-2.64, P ¼ 0.04) while weight loss X2.5 kg was not associated with BCR (hazards ratio ¼ 0.83, 95% CI: 0.54-1.29, P ¼ 0.41).
CONCLUSIONS:As a continuous variable, weight change was not associated with outcome. In secondary hypothesisgenerating analyses, weight gain X2.5 kg in the year before surgery, regardless of final body mass index, was associated with increased BCR following RP. If validated, these data suggest weight gain X2.5 kg may promote prostate cancer progression.